Rachel has been an NHS hospital pharmacist for 30 years and has been working as a neurology specialist pharmacist for the last 20. She works as part of the MS team at Imperial College NHS Trust in London on the safe provision of medicines to MS patients and has overseen the development of a pharmacy-led DMT prescribing & monitoring service at the trust. She is a non-medical prescriber of DMTs in MS& runs a clinic discussing DMT choices with pwMS.

Rachel is a member of the Faculty of the Royal Pharmaceutical Society (RPS) and is credentialled by the RPS as a consultant pharmacist. She is a UKCPA (United Kingdom Clinical Pharmacist Association) Neurosciences group committee member. She is on the MS Trust advisory board & the national MS pregnancy expert group. Rachel has also worked extensively with NHSE as part of the MS working group, looking at the commissioning of MS DMTs & the provision of MS services in England.

EAN Reports 2020:

• Paediatric MS and NMO
• DMT safety issues

COVID webinars:

• Q&A with your MS pharmacist about DMTs
• #MSCovid19 Question Time | 27 March 2020
• #MSCovid19 Quesion Time | 03 April 2020
• MS Variance: Monitoring DMTs and the costs associated with good care
• Neuropharmacist faculty member’s project featured in MS Trust publication
• MS MasterClass project: Impact of a pharmacy-led prescribing service on the monitoring of natalizumab patients
• Pharmacy-led prescribing of natalizumab in MS patients improves the quality of monitoring and overall safety

Watch videos:

• MS Variance: DMT Monitoring
• Webinar: #MSCovid19 Question Time